HIA
GILD icon

HFM Investment Advisors’s Gilead Sciences GILD Stock Holding History

HFM Investment Advisors’s Portfolio GILD Stock Details GILD Fund Activity
Bought
Maintained
Sold
Quarter Market Value Status Shares Change in
Stake 		Trade Value Portfolio Weight Portfolio Position
2026
Q2 		$7.71K Buy
61
+28
+85% +$3.69K ﹤0.01% 139
2026
Q1 		$4.6K Sell
33
-25
-43% -$3.5K ﹤0.01% 157
2025
Q4 		$7.12K Buy
58
+26
+81% +$3.16K ﹤0.01% 148
2025
Q3 		$3.55K Sell
32
-1
-3% -$114 ﹤0.01% 138
2025
Q2 		$3.66K Buy
33
+19
+136% +$2.02K ﹤0.01% 139
2025
Q1 		$1.57K Buy
+14
New +$1.45K ﹤0.01% 137

Other funds holding GILD

BlackRock
BlackRock New York $6.73T AUM 46.02% 1-Year Est. Return
Vanguard Capital Management
Vanguard Capital Management Malvern, Pennsylvania $4.68T AUM
Fidelity Investments
Fidelity Investments Boston, Massachusetts $2.3T AUM 54.33% 1-Year Est. Return
State Street
State Street Boston, Massachusetts $3.37T AUM 44.26% 1-Year Est. Return
Capital World Investors
Capital World Investors Los Angeles, California $846B AUM 46.74% 1-Year Est. Return
Invesco
Invesco Atlanta, Georgia $1.26T AUM 61.52% 1-Year Est. Return
Vanguard Portfolio Management
Vanguard Portfolio Management Malvern, Pennsylvania $2.22T AUM
Geode Capital Management
Geode Capital Management Boston, Massachusetts $1.88T AUM 44.46% 1-Year Est. Return
T. Rowe Price Associates
T. Rowe Price Associates Baltimore, Maryland $999B AUM 46.22% 1-Year Est. Return
Morgan Stanley
Morgan Stanley New York $1.89T AUM 35.08% 1-Year Est. Return

HFM Investment Advisors's GILD Position: Q2 2026 in Review

HFM Investment Advisors increased its Gilead Sciences (GILD) stake by 85% in Q2 2026, buying an estimated $3.69K and bringing the position to 61 shares worth $7.71K. The position accounts for ﹤0.01% of the portfolio, ranked #139.

HFM Investment Advisors first reported a position in GILD in Q1 2025 and has held it in 6 quarters since. 2,268 funds tracked by Wall St. Rank hold GILD as of Q2 2026.

  • HFM Investment Advisors held 61 shares of Gilead Sciences worth $7.71K as of Q2 2026.
  • HFM Investment Advisors bought 28 Gilead Sciences shares in Q2 2026, an estimated $3.69K.
  • Gilead Sciences made up ﹤0.01% of HFM Investment Advisors's portfolio in Q2 2026, its #139 holding.
  • HFM Investment Advisors first reported a position in Gilead Sciences in Q1 2025 and has held it in 6 quarters since.
  • 2,268 funds tracked by Wall St. Rank held Gilead Sciences as of Q2 2026.

Based on HFM Investment Advisors's 13F filing for Q2 2026, filed 4 Aug 2026.